Overview

The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block

Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
In this single-center, randomized, parallel control clinical trial, patients will be randomly assigned to two groups. The treatment group receives ultrasound-guided erector spinae plane block with routine treatment of Acute Gastrointestinal Injury (AGI) for 7 days or until transferred to the general ward, while the control group only receives routine treatment of AGI. The primary outcome is the cure and remission rate of AGI.
Phase:
N/A
Details
Lead Sponsor:
Zhujiang Hospital
Treatments:
Ropivacaine